AU5695294A - Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120 - Google Patents
Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120Info
- Publication number
- AU5695294A AU5695294A AU56952/94A AU5695294A AU5695294A AU 5695294 A AU5695294 A AU 5695294A AU 56952/94 A AU56952/94 A AU 56952/94A AU 5695294 A AU5695294 A AU 5695294A AU 5695294 A AU5695294 A AU 5695294A
- Authority
- AU
- Australia
- Prior art keywords
- hiv
- carbohydrate
- region
- monoclonal antibodies
- antibodies against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000713772 Human immunodeficiency virus 1 Species 0.000 title 1
- 150000001720 carbohydrates Chemical class 0.000 title 1
- 230000001419 dependent effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86088992A | 1992-03-31 | 1992-03-31 | |
US860889 | 1992-03-31 | ||
PCT/US1993/003044 WO1993020104A1 (en) | 1992-03-31 | 1993-03-31 | Monoclonal antibodies against a carbohydrate-dependent epitope related to the v2 region of hiv-1 gp120 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5695294A true AU5695294A (en) | 1994-03-15 |
Family
ID=25334289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU56952/94A Abandoned AU5695294A (en) | 1992-03-31 | 1993-03-31 | Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5695294A (en) |
WO (1) | WO1993020104A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69111440T2 (en) * | 1990-04-03 | 1996-03-28 | Genentech Inc | METHODS AND COMPOSITIONS FOR Vaccination Against HIV. |
US7041293B1 (en) | 1990-04-03 | 2006-05-09 | Genentech, Inc. | HIV env antibodies |
AU700371B2 (en) | 1993-06-07 | 1999-01-07 | Genentech Inc. | Hiv envelope polypeptides |
US6585979B1 (en) | 1996-07-08 | 2003-07-01 | Genentech, Inc. | HIV envelope polypeptides and immunogenic composition |
-
1993
- 1993-03-31 WO PCT/US1993/003044 patent/WO1993020104A1/en active Application Filing
- 1993-03-31 AU AU56952/94A patent/AU5695294A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1993020104A1 (en) | 1993-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT66445A (en) | Monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 | |
AU4985496A (en) | Administration of a cyclosporine-specific monoclonal antibody that cross-reacts with hiv-1 p24 gag to treat hiv infection | |
AU2981992A (en) | Expression of specific immunogens using viral antigens | |
EP0777497A4 (en) | Human neutralizing monoclonal antibodies to human immunodeficiency virus | |
HU896763D0 (en) | Process for the preparation of bispecific monoclonal antibody | |
CA2081150A1 (en) | Use of antibody-containing preparations for immunosuppression | |
AU4618193A (en) | Humanized antibodies | |
ZA884651B (en) | Monoclonal antibody specific to hiv antigens | |
AU6080794A (en) | Antibodies directed against binding-associated epitopes | |
AU3459593A (en) | Humanised antibody against hepatitis | |
AU2784792A (en) | Human monoclonal antibodies to the cd4-binding domain of hiv, uses thereof and synergistic neutralization of hiv | |
AU7203194A (en) | Bispecific human monoclonal antibodies specific for human immunodeficiency virus | |
AU3330689A (en) | Monoclonal antibodies | |
AU7160691A (en) | Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes | |
AU5695294A (en) | Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120 | |
IL94624A0 (en) | Human monoclonal antibodies to hiv-1 mn qq120 | |
AU2370592A (en) | Epitopes of the env protein of the hepatitis c virus | |
EP0511300A4 (en) | Monoclonal antibody specific for non-immunodominant epitope of hiv proteins | |
AU4959193A (en) | High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus | |
HU9501328D0 (en) | Production of human monoclonal antibodies active against hepatitis b surface antigen | |
AU7184191A (en) | Sperm antigen corresponding to a sperm autoantigenic epitope and methods of using the same | |
AU680836B2 (en) | Human monoclonal antibodies to human immunodeficiency virus | |
AU8268491A (en) | Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses | |
AU1820692A (en) | Novel anti-hiv antibodies | |
GB2279076B (en) | Antibodies to fungal antigens |